Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mediglimp Trio 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Medisave

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Mediglimp Trio 2mg/500mg/0.2mg Tablet

Tridiomet 2mg/500mg/0.2mg tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults, effectively managing blood glucose levels. Administer Tridiomet with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize its symptoms – sweating, dizziness, headache, tremors – and how to counter them using fast-acting glucose sources (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Primary Ingredients of Mediglimp Trio 2mg/500mg/0.2mg Tablet

No text provided to rephrase.

Uses of Mediglimp Trio 2mg/500mg/0.2mg Tablet

Managing Type 2 Diabetes

Major Benefits of Mediglimp Trio 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Mediglimp Trio 2mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Mediglimp Trio 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Mediglimp Trio 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Mediglimp Trio 2mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Mediglimp Trio 2mg/500mg/0.2mg Tablet works:

This tablet, Mediglimp Trio (2mg/500mg/0.2mg), contains a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Mediglimp Trio 2mg/500mg/0.2mg Tablets should not be taken with alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Mediglimp Trio 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Mediglimp Trio 2mg/500mg/0.2mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Mediglimp Trio 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, its use is contraindicated in patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Mediglimp Trio 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, initiation with a reduced dose is typical; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Mediglimp Trio 2mg/500mg/0.2mg Tablet :

Should you forget a Mediglimp Trio 2mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mediglimp Trio 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Mediglimp Trio 2mg/500mg/0.2mg Tablet

Mediglimp Trio 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Mediglimp Trio 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Mediglimp Trio 2mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Mediglimp Trio 2mg/500mg/0.2mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Mediglimp Trio 2mg/500mg/0.2mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication, tightly sealed, in its original packaging. Follow the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Mediglimp Trio 2mg/500mg/...
115
MRP 140
17% off